Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Sonoma Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q4 2023
- Shares held
- 164.3K
- −139.5K (−45.9%) vs. Q4 2023
- Total value
- $27.3K
- −$27.5K (−50.1%) vs. Q4 2023
- New holders
- 4
- 2 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNOA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $136.3K |
| Q1 2026 | 17 | $143.7K |
| Q4 2025 | 16 | $396.4K |
| Q3 2025 | 20 | $230.3K |
| Q2 2025 | 14 | $242.0K |
| Q1 2025 | 12 | $71.5K |
| Q4 2024 | 9 | $54.2K |
| Q3 2024 | 14 | $85.2K |
| Q2 2024 | 20 | $91.7K |
| Q1 2024 | 16 | $27.3K |
| Q4 2023 | 17 | $54.8K |
| Q3 2023 | 13 | $97.3K |
| Q2 2023 | 16 | $175.0K |
| Q1 2023 | 18 | $143.5K |
| Q4 2022 | 15 | $159.3K |
| Q3 2022 | 17 | $396.0K |
| Q2 2022 | 18 | $540.0K |
| Q1 2022 | 18 | $687.0K |
| Q4 2021 | 18 | $806.0K |
| Q3 2021 | 21 | $1.19M |
| Q2 2021 | 21 | $1.56M |
| Q1 2021 | 19 | $1.32M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Sonoma Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 46,052 | $7.66K | 0.00% | +46,052 | New |
| Geode Capital Management, LLC | 35,780 | $5.95K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,315 | $4.04K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 16,463 | $2.74K | 0.00% | +16,463 | New |
| Two Sigma Securities, LLC | 13,473 | $2.24K | 0.00% | +13,473 | New |
| Millennium Management LLC | 13,016 | $2.17K | 0.00% | −18,881−59.2% | Reduced |
| Tower Research Capital LLC (TRC) | 11,980 | $1.99K | 0.00% | +2,462+25.9% | Added |
| BlackRock Inc. | 2,266 | $377 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 500 | $83 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 122 | $20 | 0.00% | +17+16.2% | Added |
| UBS Group AG | 103 | $17 | 0.00% | −8,833−98.8% | Reduced |
| Morgan Stanley | 86 | $14 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 65 | $11 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 44 | $7 | 0.00% | 00.0% | Unchanged |
| HBC Financial Services, PLLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 6 | $0 | 0.00% | +6 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −116,779−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −33,049−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,862−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,111−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2,463−100.0% | Sold out |